Back to Awarded Treatment Trials
Awarded Trial: 02T-123
Grant ID
02T-123
Illness
Bipolar and Unipolar Depression
Primary Drug/Intervention
Ropinirole
Primary Dosage
2 mg b.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Grunhaus
Sample Size
60
Duration of Study Period for Each Subject
7 weeks
Outcome Measurements
HAM-D
Results
Thirty-two patients completed the study. There was no beneficial effect of ropinirole over placebo.
Publication
N/A
Link
N/A
PI Name
Leon Grunhaus
Degree
MD
Center
Sheba Medical Center
Institution
The Chaim Sheba Medical Center, Medical Research Dev.
Address
Psychiatry Department C
City or Town
Tel Hashomer
State or Province
N/A
Zip or Postal Code
52621
Country
Israel
Email Address
kfrgrunhaus@matat.health.gov.il